AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Kieran
Pediatric Brain Tumor Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- Dana-Farber/harvard Cancer Center
Boston, Massachusetts, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Pediatric Brain Tumor Consortium
Memphis, Tennessee, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- 31 Jul 2015
- Completion
- 31 Jul 2015
- Last update posted
- 7 Mar 2016
- Registered enrollment
- 55
- Registry id
- NCT00326664
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.